Yumanity Therapeutics Inc YMTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:06 PM EST
1.80quote price arrow up+0.02 (+0.93%)
Volume
18,350
52 week range
0.95 - 4.40
Loading...
  • Open1.77
  • Day High1.85
  • Day Low1.77
  • Prev Close1.79
  • 52 Week High4.40
  • 52 Week High Date11/29/21
  • 52 Week Low0.95
  • 52 Week Low Date03/14/22

Key Stats

  • Market Cap19.56M
  • Shares Out10.86M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta0.30
  • YTD % Change-39.13

KEY STATS

  • Open1.77
  • Day High1.85
  • Day Low1.77
  • Prev Close1.79
  • 52 Week High4.40
  • 52 Week High Date11/29/21
  • 52 Week Low0.95
  • 52 Week Low Date03/14/22
  • Market Cap19.56M
  • Shares Out10.86M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta0.30
  • YTD % Change-39.13

RATIOS/PROFITABILITY

  • EPS (TTM)-3.00
  • P/E (TTM)-0.60
  • Fwd P/E (NTM)-0.43
  • EBITDA (TTM)-27.041M
  • ROE (TTM)-168.67%
  • Revenue (TTM)4.844M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-660.61%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date03/22/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Yumanity Therapeutics Inc

 

Profile

MORE
Yumanity Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of disease-modifying therapies for neurodegenerative diseases. The Company’s pipeline consists of programs focused on Parkinson’s disease, Lewy body dementia, multi-system atrophy, amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease), frontotemporal lobar dementia (FTLD), and Alzheimer’s disease. The Company's technology platform enables the...
N. Anthony Coles Jr., M.D.
Non-Executive Chairman of the Board
Richard Peters M.D., Ph.D.
President, Chief Executive Officer, Director
Michael Wyzga
Chief Financial Officer, Senior Vice President, Treasurer
Address
40 GUEST STREET, SUITE 4410
Boston, MA
02135
United States

Top Peers

SYMBOLLASTCHG%CHG
ERYP
Erytech Pharma SA
0.6026UNCHUNCH
PULM
Pulmatrix Inc
3.63+0.06+1.68%
EFTR
eFFECTOR Therapeutics Inc
0.4301-0.0087-1.9827%
HGEN
Humanigen Inc
0.1457-0.0028-1.8855%
CBIO
Catalyst Biosciences Inc
0.5505+0.0004+0.0727%
APVO
Aptevo Therapeutics Inc
3.05+0.16+5.54%